These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
18. Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells. Benedetti L, Levin AA, Scicchitano BM, Grignani F, Allenby G, Diverio D, Lo Coco F, Avvisati G, Ruthardt M, Adamo S, Pelicci PG, Nervi C. Blood; 1997 Aug 01; 90(3):1175-85. PubMed ID: 9242550 [Abstract] [Full Text] [Related]
19. Mutant AF-2 domain of PML-RARalpha in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARalpha and its down-regulation in acute promyelocytic leukemia. Kitamura K, Kiyoi H, Yoshida H, Saito H, Ohno R, Naoe T. Leukemia; 1997 Nov 01; 11(11):1950-6. PubMed ID: 9369431 [Abstract] [Full Text] [Related]
20. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Rego EM, He LZ, Warrell RP, Wang ZG, Pandolfi PP. Proc Natl Acad Sci U S A; 2000 Aug 29; 97(18):10173-8. PubMed ID: 10954752 [Abstract] [Full Text] [Related] Page: [Next] [New Search]